Interested in stem cell developments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Inhaled #Aviptadil Study Start Date January 10, 2021.
https://clinicaltrials.gov/ct2/show/record/NCT04360096?view=record
Vaccine progress is fantastic. But therapeutics can help Covid patients now
Vaccine development has gotten the lion’s share of funding - leaving important therapeutic trials ignored and underfunded.
https://www.theguardian.com/commentisfree/2020/dec/10/vaccine-progress-is-fantastic-but-therapeutics-can-help-covid-patients-now
Fitbit, to have an effect impact on the powers that be the unblinding has to be done by the DSMB.
Sadly NO ONE WILL REALLY SEE IT...
UK issues allergy warning about Pfizer COVID-19 vaccine after patients fall ill
https://nypost.com/2020/12/09/uk-issues-warning-about-pfizers-covid-19-vaccine/
Pfizer-BioNTech and AstraZeneca data revealed; Senate hearing highlights medical uncertainties
The coronavirus pandemic is poised to peak in a month as a confluence of Thanksgiving aftermath+upcoming holidays will send cases+hospitalizations skyrocketing.
https://finance.yahoo.com/news/coronavirus-update-pfizer-bio-n-tech-and-astra-zeneca-data-revealed-senate-hearing-highlights-medical-uncertainties-182607742.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
Assessing the legal duty to use or disclose interim data for ongoing clinical trials
Randomized controlled clinical trials, leading to large-scale meta-analyses, are considered the gold standard for research evaluating new drugs and other therapeutic interventions. To promote scientific integrity and prevent the adoption of potentially fallacious early trends, emerging information is commonly shielded from sponsors, investigators, and other clinical trial actors, including through the use of independent Data and Safety Monitoring Boards (DSMBs). Once established, a DSMB is usually the only body to have access to unblinded information until trial completion or the crossing of pre-specified, and often highly stringent, stopping boundaries. Yet, in certain circumstances, clinical trial actors have legal obligations to trial participants and others to use or disclose emerging information.
This paper canvasses potential legal obligations to use or disclose emerging clinical trial data, including through tort law and securities laws. The analysis is supplemented by a comprehensive search of US cases in which courts have adjudicated upon such allegations. Notably, available cases demonstrate widespread judicial deference to clinical trial practices designed to shield clinical trial actors from emerging information.
A promising drug against COVID-19 the world was waiting for, RLF100 (Aviptadil)
https://link.medium.com/6rj1gMLKWbb
Great Plains Health Severe COVID-19 Patients Benefit from RLF-100
https://trialsitenews.com/great-plains-health-severe-covid-19-patients-benefit-from-rlf-100/
When I posted the article and a bit later posted a quote from it this was what it said:
My post:
At the very end of the article Woodun does say:
Finally, Relief has a strong vaccine candidate based on the fact that it uses VIP, which was present in significantly higher levels in the blood samples of those patients who did NOT die because of respiratory failure.
Finally, Relief has a strong drug candidate based on the fact that it uses VIP, which was present in significantly higher levels in the blood samples of those patients who did NOT die because of respiratory failure.
At the very end of the article Woodun does say:
Finally, Relief has a strong vaccine candidate based on the fact that it uses VIP, which was present in significantly higher levels in the blood samples of those patients who did NOT die because of respiratory failure.
Fitbit, why do you keep harping on the vote. If you don't know that the powers that be have the vote locked up then you need to work first on the major beam in your own eye.
I am guessing the Swiss market is not closed. Anyone know?
I would bet, though no evidence yet, that treatment with Aviptadil lowers the number of so called "long haulers" and also lowers the intensity of "long hauler" symptoms.
That's close enough. Now I will have to double my bet.
Do you have a link as to which 25 US hospitals those are?
How many of your babies were born on the 10th?
We are not yet at the level of a major breakthrough. That may come soon but it is not something that
most of us can play much of a role in bringing about, not even Vanilla Fitbit. We basically have to make our judgements on the management team and whether they have the intelligence, competence and connections to bring this home. None of us can be sure but the signs so far tell me they have an excellent treatment and have a very good chance to get it established.
Imagine what might happen if they get an EAU and an EUA at the same time.
There is no difference between inhaled or injected versions other than preparation prior to administration.
Vanilla Fitbit has a list of RT problems but all he does is yap, yap, yap about them. If he has done anything about them it has amounted to very little and is nowhere near enough. When is Fitbit going to produce some results?
It sounds like the number of doses can be ramped up very quickly since we have previously been informed that VIP can be manufactured synthetically (i.e. Aviptadil or RLF100) in huge quantities and relatively inexpensively.
Mumps was the quickest effective vaccine to market. Four years.
To diseases practically eliminated or greatly reduced thanks to vaccines you can add diphtheria, chicken pox, small pox, measles, mumps, rubella and HPV.
Another good one.
LAB-GROWN MINI-LUNGS MIMIC THE REAL THING – RIGHT DOWN TO COVID INFECTION
Living human lung air sacs in tiny dishes promise to accelerate Covid research
Baric’s lab is capable of changing any nucleotide of the Covid-19 virus’s genetic code at will, so it produced a glowing version that would reveal where it went in the mini-lungs, confirming that it did indeed home in on the crucial ACE2 cell surface receptor, leading to infection.
When infected with the virus, the organoids were shown to launch an inflammatory response mediated by interferons. The researchers have also witnessed the cytokine storm of immune molecules the lungs launch in response to the virus.
“It was thought cytokine storm happened due to the large influx of immune cells, but we can see it also happens in the lung stem cells themselves,” Tata said.
https://today.duke.edu/2020/10/lab-grown-mini-lungs-mimic-real-thing-%E2%80%93-right-down-covid-infection#.X7gRZbQCsio.twitter
Influenza virus attachment to cells: role of different sialic acids
Dr. Peter Palese….considers the mixing-bowl theory unnecessary to explain antigen shift: “It’s equally likely that co-infection of avian and human virus in a human in one cell in the lung [gives] rise to the virus…There’s no reason why mixing couldn’t occur in the lung, whether in pig or man.
https://www.virology.ws/2009/05/05/influenza-virus-attachment-to-cells-role-of-different-sialic-acids/
Let's hope there are many $DahlAhs along the Roald ahead.
We should, however, make it clear to the world that whatever differences of opinion surface here over many issues there is still totally BI-PARTISAN SUPPORT FOR RLF-100 and its safety and its genuine and powerful efficacy. It seems likely that, if they know about it, even those from the extremes of the political spectrum support RLF-100.
Could something like this happen in the RLFTF set-up?
Tesoro Enterprises, Inc. Retires Over 551 Million Common Shares
https://finance.yahoo.com/news/tesoro-enterprises-inc-retires-over-140000750.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
Buy the rumor?
A good possibility. As we know big pharma does not necessarily have its first eye on reducing deaths of us regular people when a treatment is not chronic.
"emphasized that aviptadil isn’t a silver bullet and that studies are needed before the medication can be used widely to treat COVID-19."
LOL Now you made look to see who it was. I am not Asan Abdiev.
True. I responded too quickly to it having come out today and before a careful reading of it.
Anyone know ANY OTHER COVID therapeutic showing results with diagnostic imaging!!!
Excellent point.
Below $0.40 COVID-19 Stock To Achieve High Margins: Relief Therapeutics (RLFTF)
https://ownsnap.com/below-0-40-covid-19-stock-to-achieve-high-margins-relief-therapeutics-rlftf/
One article states:
It will last for only 24 hours at refrigerated temps between 35.6° and 46.4°
Thank God I am seeing 6,627,421M, so not a bad omen on Yahoo.